pharmacokinetic

2012-2013 Psychiatric Pharmacy Review Course Course Components (ACPE Only)

The 2012-2013 CPNP Psychiatric Pharmacotherapy Review Course (ACPE Only) includes the following:

Pharmacokinetic effects of bariatric surgery.

Edwards A, Ensom MHH. Pharmacokinetic effects of bariatric surgery. Ann Pharmacother. 2012;46(1):130-6. DOI: 10.1345/aph.1Q414. PubMed PMID: 22190251.

Course Components

The APNA Endorsed CPNP Psychiatric Pharmacotherapy Review Course includes the following:

Pharmacokinetic assessment of peramivir in a hospitalized adult undergoing continuous venovenous hemofiltration.

Scheetz MH, Griffith MM, Ghossein C, Hollister AS, Ison MG. Pharmacokinetic assessment of peramivir in a hospitalized adult undergoing continuous venovenous hemofiltration. Ann Pharmacother. 2011;45(12):e64. DOI: 10.1345/aph.1Q437. PubMed PMID: 22116989.

Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients.

Aubron C, Corallo CE, Nunn MO, Dooley MJ, Cheng AC. Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients. Ann Pharmacother. 2011;45(10):1193-8. DOI: 10.1345/aph.1Q195. PubMed PMID: 21896920.

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behavi

Deiana S, Watanabe A, Yamasaki Y, Amada N, Arthur M, Fleming S, et al. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behavi. Psychopharmacology. 2012;219(3):859-73. DOI: 10.1007/s00213-011-2415-0. PubMed PMID: 21796370.

Comparative pharmacokinetic analysis of USL255, a new once-daily extended-release formulation of topiramate.

Lambrecht LJ, Shekh-Ahmad T, Todd WM, Halvorsen MB, Bialer M. Comparative pharmacokinetic analysis of USL255, a new once-daily extended-release formulation of topiramate. Epilepsia. 2011;52(10):1877-83. DOI: 10.1111/j.1528-1167.2011.03183.x. PubMed PMID: 21770925.

Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.

Nunn MO, Corallo CE, Aubron C, Poole S, Dooley MJ, Cheng AC. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software. Ann Pharmacother. 2011;45(6):757-63. DOI: 10.1345/aph.1P634. PubMed PMID: 21652786.

The use of healthy volunteers instead of patients to inform drug dosing studies: a [¹¹C]raclopride PET study.

Kim E, Howes OD, Kim B-H, Yu K-S, Jeong JM, Lee JS, et al. The use of healthy volunteers instead of patients to inform drug dosing studies: a [¹¹C]raclopride PET study. Psychopharmacology. 2011;217(4):515-23. DOI: 10.1007/s00213-011-2306-4. PubMed PMID: 21503604.